Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) President Jon Christianson sold 528 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $127.75, for a total transaction of $67,452.00. Following the completion of the transaction, the president directly owned 66,970 shares of the company’s stock, valued at $8,555,417.50. This trade represents a 0.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Jon Christianson also recently made the following trade(s):
- On Monday, July 20th, Jon Christianson sold 3,000 shares of Palomar stock. The shares were sold at an average price of $139.50, for a total transaction of $418,500.00.
- On Thursday, July 2nd, Jon Christianson sold 6,863 shares of Palomar stock. The stock was sold at an average price of $139.50, for a total value of $957,388.50.
Palomar Stock Performance
PLMR stock opened at $130.09 on Friday. The business’s 50-day moving average price is $130.76 and its two-hundred day moving average price is $123.92. The company has a current ratio of 0.50, a quick ratio of 0.50 and a debt-to-equity ratio of 0.30. The firm has a market cap of $3.42 billion, a PE ratio of 17.49 and a beta of 0.40. Palomar Holdings, Inc. has a 1-year low of $100.81 and a 1-year high of $147.62.
Palomar Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 2nd. Stockholders of record on Wednesday, August 19th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 1.4%. The ex-dividend date is Wednesday, August 19th. Palomar’s payout ratio is 24.19%.
Key Palomar News
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Strong premium growth and expansion in specialty insurance are expected to support Palomar’s earnings momentum. Analysts’ average price target of $162.75 and recent target increases reinforce the bullish view. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
- Positive Sentiment: Dowling & Partners expressed a positive view of Palomar’s fiscal 2026 earnings outlook, adding to expectations for continued profit growth. DOWLING & PARTN Has Positive View of Palomar FY2026 Earnings
- Positive Sentiment: Palomar’s latest quarterly results provide fundamental support: earnings per share of $2.36 exceeded the $2.19 consensus estimate, while profitability and return on equity remained strong.
- Neutral Sentiment: Several insiders, including the president, CFO and Jonathan Knutzen, sold relatively small portions of their holdings to cover tax withholding on vested equity awards. Because the transactions were not discretionary sales, they are less negative than typical insider selling, though they may limit near-term sentiment.
- Neutral Sentiment: Palomar declared a quarterly dividend of $0.45, equivalent to $1.80 annually and a yield of approximately 1.4%, providing modest shareholder support.
- Negative Sentiment: Competitive pricing could reduce premium profitability, while a higher combined ratio would pressure underwriting margins. These risks may temper the market’s response to otherwise strong growth expectations. Can Strong Premium Growth Sustain Palomar’s Earnings Momentum?
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of PLMR. Geneos Wealth Management Inc. acquired a new stake in Palomar in the 4th quarter valued at approximately $32,000. Kestra Advisory Services LLC acquired a new position in Palomar during the 4th quarter worth approximately $33,000. Rockefeller Capital Management L.P. grew its stake in shares of Palomar by 81.5% during the 4th quarter. Rockefeller Capital Management L.P. now owns 294 shares of the company’s stock worth $40,000 after acquiring an additional 132 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Palomar during the 2nd quarter worth approximately $43,000. Finally, Frazier Financial Advisors LLC acquired a new stake in shares of Palomar in the second quarter valued at approximately $51,000. 90.25% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts have commented on PLMR shares. Evercore set a $152.00 target price on shares of Palomar in a report on Friday, July 10th. Piper Sandler upped their price target on shares of Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Keefe, Bruyette & Woods increased their price objective on shares of Palomar from $166.00 to $167.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. JPMorgan Chase & Co. increased their price objective on shares of Palomar from $150.00 to $167.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. Finally, Zacks Research cut shares of Palomar from a “strong-buy” rating to a “hold” rating in a research report on Friday, May 15th. Four analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $162.75.
Get Our Latest Stock Analysis on PLMR
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Read More
- Five stocks we like better than Palomar
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
